John B. Porter

20.8k citations

489 papers · 15.4k · 2 hit papers · h-index 65

Impact in

Genetics top 0.01%
- Hemoglobinopathies and Related Disorders
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Hematology top 0.02%
- Iron Metabolism and Disorders
- Blood groups and transfusion
- Erythropoietin and Anemia Treatment

Papers in

Genetics 332
- Hemoglobinopathies and Related Disorders 331
Hematology 244
- Iron Metabolism and Disorders 184
- Blood groups and transfusion 50
- Erythropoietin and Anemia Treatment 33

Co-authors: Robert C. Hider (49 shared papers)Maria Domenica Cappellini (81 shared papers)Alì Taher (80 shared papers)Bernard A. Davis (12 shared papers)Dudley J. Pennell (42 shared papers)Maciej Garbowski (29 shared papers)Vip Viprakasit (52 shared papers)Alan R. Cohen (14 shared papers)
Journals: Blood (148 papers)British Journal of Haematology (30 papers)Journal of Cardiovascular Magnetic Resonance (14 papers)Haematologica (13 papers)American Journal of Hematology (10 papers)
Partner nations: United Kingdom United States Italy

In The Last Decade

John B. Porter

470 papers receiving 14.7k citations

John B. Porter's Hit Papers

align trajectories log scale

2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia 2022 · 133 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 HemaSphere
2014 Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT)

Peers

Countries citing papers authored by John B. Porter

Since Specialization

Citations

This map shows the geographic impact of John B. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John B. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John B. Porter more than expected).

Fields of papers citing papers by John B. Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John B. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John B. Porter. The network helps show where John B. Porter may publish in the future.

Co-authors

The 25 scholars most cited alongside John B. Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John B. Porter Line = papers co-authored together John B. Porter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 489 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major Circulation ·Paul Kirk, Sy Ha, John B. Porter, John M. Walker, Mark Tanner, Jitesh A. Patel, D. Wu, Janet L. Taylor, Mark A. Westwood, Lisa Anderson, Dudley J. Pennell	2009	460
2	On T2* Magnetic Resonance and Cardiac Iron Circulation ·John‐Paul Carpenter, Taigang He, Paul Kirk, Sy Ha, (unknown), Sofia V. de Noronha, Mary N. Sheppard, John B. Porter, John M. Walker, John C. Wood, Renzo Galanello, (unknown), Gualtiero Catani, Gildo Matta, Suthat Fucharoen, Adam Fleming, Michael J. House, Greg Black, David Firmin, Timothy G. St. Pierre, Dudley J. Pennell	2011	369
3	Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance British Journal of Haematology ·(unknown), Mark A. Westwood, Sally Holden, Bernard A. Davis, Eva Prescott, B. Wonke, John B. Porter, John M. Walker, Dudley J. Pennell	2004	332
4	Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT) Maria Domenica Cappellini, Alan R. Cohen, John B. Porter, Alì Taher, Vip Viprakasit Hit paper breakdown →	2014	312
5	Practical management of iron overload British Journal of Haematology ·John B. Porter	2001	306
6	Cardiovascular Function and Treatment in β-Thalassemia Major Circulation ·Dudley J. Pennell, James E. Udelson, Andrew E. Arai, Biykem Bozkurt, Alan R. Cohen, Renzo Galanello, Timothy M. Hoffman, (unknown), Stamatios Lerakis, Antonio Piga, John B. Porter, John M. Walker, John C. Wood	2013	305
7	Oxidative stress and inflammation in iron‐overloaded patients with β‐thalassaemia or sickle cell disease British Journal of Haematology ·Patrick B. Walter, Ellen B. Fung, David W. Killilea, Qing Jiang, Mark Hudes, Jacqueline Madden, John B. Porter, Patricia Evans, Elliott Vichinsky, Paul Harmatz	2006	254
8	Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias Haematologica ·Maria Domenica Cappellini, John B. Porter, Amal El‐Beshlawy, Chi Kong Li, JANE F. SEYMOUR, Mohsen Saleh Elalfy, Norbert Gattermann, Stéphane Giraudier, J. W. Lee, L L Chan, Kai‐Hsin Lin, Christian Rosé, Alì Taher, SL Thein, Vip Viprakasit, Dany Habr, Gabor Domokos, Bernard Roubert, Antonis Kattamis, (unknown)	2009	240
9	Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk β-thalassemia Blood ·Bernard A. Davis, John B. Porter	2000	239
10	A randomised comparison of deferasiroxversusdeferoxamine for the treatment of transfusional iron overload in sickle cell disease British Journal of Haematology ·Elliott Vichinsky, Onyinye Onyekwere, John B. Porter, Paul Swerdlow, James R. Eckman, Peter S Lane, Beatrice Files, Kathryn Hassell, Patrick Kelly, Felicia Wilson, Françoise Bernaudin, (unknown), Iheanyi Okpala, C. Ressayre-Djaffer, Daniele Alberti, Jaymes Holland, Peter Marks, Ellen B. Fung, Roland A. Fischer, Brigitta U. Mueller, Thomas D. Coates, (unknown)	2006	225
11	Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential Journal of Medicinal Chemistry ·Paul S. Dobbin, Robert C. Hider, Adrian D. Hall, Paul Taylor, P Sarpong, John B. Porter, Gaoyi Xiao, Dick Van der Helm	1993	203
12	Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy Blood ·John B. Porter, RD Abeysinghe, Lysette Marshall, Robert C. Hider, Surinder Singh	1996	169
13	Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up Blood ·Maria Domenica Cappellini, Mohamed Béjaoui, Leyla Ağaoğlu, Duran Canatan, Marcello Capra, Alan R. Cohen, Guillermo Drelichman, Marina Economou, Slaheddine Fattoum, Antonis Kattamis, Yurdanur Kılınç, Silverio Perrotta, Antonio Piga, John B. Porter, Louis Griffel, Victor Dong, Joan Clark, Yeşim Aydınok	2011	168
14	Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia Blood ·Dudley J. Pennell, John B. Porter, Maria Domenica Cappellini, Amal El‐Beshlawy, Lee Lee Chan, Yeşim Aydınok, Mohsen Saleh Elalfy, Pranee Sutcharitchan, Chi Kong Li, Hishamshah Mohd Ibrahim, Vip Viprakasit, Antonis Kattamis, Gillian Smith, Dany Habr, Gabor Domokos, Bernard Roubert, Alì Taher	2009	165
15	The Relationship of Intracellular Iron Chelation to the Inhibition and Regeneration of Human Ribonucleotide Reductase Journal of Biological Chemistry ·Chris E. Cooper, Gayle R. Lynagh, Katharine P. Hoyes, Robert C. Hider, Richard Cammack, John B. Porter	1996	157
16	Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan Journal of Cardiovascular Magnetic Resonance ·Maciej Garbowski, John‐Paul Carpenter, Gillian Smith, Sy Ha, Mohammed H Alam, Taigang He, Dudley J. Pennell, John B. Porter	2014	155
17	Quantification of Non-Transferrin-Bound Iron in the Presence of Unsaturated Transferrin Analytical Biochemistry ·Itsaraet Gosriwatana, Olivier Loréal, Shuli Lu, Pierre Brissot, John B. Porter, Robert C. Hider	1999	151
18	Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major Blood ·Bernard A. Davis, C. O'Sullivan, Peter H. Jarritt, John B. Porter	2004	147
19	Effect of transfusional iron intake on response to chelation therapy in β-thalassemia major Blood ·Alan R. Cohen, Ekkehard Glimm, John B. Porter	2007	144
20	Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant Blood ·John B. Porter, M. Gyparaki, LC Burke, ER Huehns, P Sarpong, V. Sáez, Robert C. Hider	1988	143

About John B. Porter

John B. Porter is a scholar working on Genetics, Hematology, Pediatrics, Perinatology and Child Health, Molecular Biology and Physiology, having authored 489 papers that have together received 15.4k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (331 papers), Iron Metabolism and Disorders (184 papers), Blood groups and transfusion (50 papers), Erythrocyte Function and Pathophysiology (43 papers), Pharmacological Effects and Toxicity Studies (43 papers), Erythropoietin and Anemia Treatment (33 papers), Trace Elements in Health (24 papers) and Drug Transport and Resistance Mechanisms (19 papers). The work is most often cited by research in Genetics (9.7k citations), Hematology (7.8k citations), Nutrition and Dietetics (1.9k citations), Pediatrics, Perinatology and Child Health (1.6k citations) and Internal Medicine (233 citations). John B. Porter has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Robert C. Hider, Maria Domenica Cappellini, Alì Taher, Bernard A. Davis, Dudley J. Pennell, Maciej Garbowski, Vip Viprakasit, Alan R. Cohen, E. R. Huehns and John M. Walker. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Cardiovascular Magnetic Resonance, Haematologica and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

John B. Porter

Impact in

Papers in i

In The Last Decade

John B. Porter

John B. Porter's Hit Papers

Peers

Countries citing papers authored by John B. Porter

Fields of papers citing papers by John B. Porter

All Works

About John B. Porter

Explore authors with similar magnitude of impact

Papers in